Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Glycosyl-phosphatidylinositol (GPI) anchored membrane proteins have been reported to be deficient on affected paroxysmal nocturnal haemoglobinuria (PNH) blood cells. In the present study we investigated the deficiency of several GPI anchored membrane proteins on PNH neutrophils (PMN) and monocytes from 10 patients with PNH. Decay-accelerating factor (DAF) and Fc gamma R-III (CD16) on PMN, DAF and CD14 on monocytes, were investigated by two-colour immunofluorocytometry. Neutrophil alkaline phosphatase activity was also assayed on PNH neutrophils. Normal human PMN were always shown phenotypically to be DAF+/CD16+. A DAF-/CD16- subpopulation of PMN was demonstrated in all the patients studied. In six out of the 10 patients, deficiencies of DAF and CD16 were found simultaneously on affected PNH PMN. The percentage of DAF- PMN showed a positive correlation with the neutrophil alkaline phosphatase (NAP) score. However, it should be noted that, in four out of the 10 patients with PNH, a DAF+/CD16- subpopulation of PMN was also clearly found. This may indicate that the deficiencies of DAF and CD16 on PNH PMN are heterogeneous. Normal human monocytes were demonstrated to be DAF+/CD14+, whereas PNH monocytes consisted of subpopulations of DAF+/CD14+ and DAF-/CD14-. In the same patients with PNH, the deficiencies of DAF on PMN and monocytes correlated well with each other. These results suggest that, at least in some patients with PNH, the mechanisms which induce the membrane defects of PNH blood cells are heterogeneous.
Kawakami
Z
Z
Division of Haematology, University of Tsukuba, Ibaraki, Japan.
Ninomiya
H
H
Tomiyama
J
J
Abe
T
T
D000328:Adult; D000943:Antigens, Differentiation / Q000032:analysis*; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D018958:CD55 Antigens; D002648:Child; D003169:Complement Inactivator Proteins / Q000172:deficiency*; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006017:Glycolipids / Q000097:blood*; D017261:Glycosylphosphatidylinositols; D006457:Hemoglobinuria, Paroxysmal / Q000276:immunology*; D006801:Humans; D018950:Lipopolysaccharide Receptors; D008297:Male; D008565:Membrane Proteins / Q000172:deficiency*; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D010716:Phosphatidylinositols / Q000097:blood*; D011961:Receptors, Fc / Q000032:analysis*; D017452:Receptors, IgG
D000943:Antigens, Differentiation; D015214:Antigens, Differentiation, Myelomonocytic; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; D006017:Glycolipids; D017261:Glycosylphosphatidylinositols; D018950:Lipopolysaccharide Receptors; D008565:Membrane Proteins; D010716:Phosphatidylinositols; D011961:Receptors, Fc; D017452:Receptors, IgG